4Wei FC, Jain V, Celik N, et al. Have we found an ideal softtissue flap? An experience with 672 anterolateral thigh flaps [J]. Plast Reconstr Surg, 2002, 109:2219.
5Lueg EA. The anterolateral thigh flap: Radial forearm's "big brother" for extensive soft tissue head and neck defects [J].Arch Otolaryngol Head Neck Surg, 2004, 130:813.
6Peretti G, Piazza C, Bolzoni A, et al. Analysis of recur- rences in 322 Tis, T1, or T2 glottic carcinomas treated by carbon dioxide laser [J]. Ann Otol Rhinol Laryngol, 2004, 113 : 853.
7Motta G, Esposito E, Motta S, et al. CO2 laser surgery in the treatment of glottic cancer [ J ]. Head Neck, 2005, 27 : 566.
8Ambrosch P, Kron M, Steiner W. Carbon dioxide laser microsurgery for early supraglottic carcinoma [ J ]. Ann Otol Rhinol Laryngol, 1998, 107:680.
9Jackel MC, Martin A, Steiner W. Twenty - five years experience with laser surgery for head and neck tumors [J]. Eur Arch Otorhinolaryngol, 2007, 264 : 577.
5Kimata Y,Uchiyama K,Ebihara S,et al.Versatility of the free anterolateral thigh flap for reconstruction of head and neck defects.Arch Otolaryngol Head Neck Surg,1997,123:1325-1331.
6Wei FC,Jain V,Celik N,et al.Have we found an ideal soft-tissue flap? An experience with 672 anterolateral thigh flaps.Plast Reconstr Surg,2002,109:2219-2226.
7Song YG,Chen GZ,Song YL.The free thigh flap:a new free flap concept based on septocutaneous artery.Br J Plast Surg,1984,37:149-159.
8Kimata Y,Uchiyama K,Ebihara S,et al.Anatomic variations and technical problems of the anterolateral thigh flap:a report of 74cases.Plast Reconstr Surg,1998,102:1517-1523.
3Gadducci A,Tana R,Cosio S,et al.The serum assay of tumourmarkers in the prognostic evaluationt,reatment monitoring and fol-low-up of patients with cervical cancer:a review of the literature[J].Crit Rev Oncol Hematol,2008,66(1):10-20.
4Yuan SH,Liang XFJ,ia WH,et al.Molecular diagnosis of sentinellymph node metastases in cervical cancer using squamous cell carci-noma antigen[J].Clin Cancer Res,2008,14(17):5571-5578.
5Kagohashi K,Satoh H,Kurishima K,et al.Squamous cell carcinomaantigen in lung cancer and nonmalignant respiratory diseases[J].Lung,2008,186(5):323-326.
6Trerotoli P,Fransvea E,Angelotti U,et al.Tissue expression of Squa-mous Cellular Carcinoma Antigen(SCCA)is inversely correlated totumor size in HCC[J].Mol Cancer,2009,27(8):29.
7Kosugi S,Nishimaki T,Kanda T,et al.Clinical significance of ser-um carcinoembryonic antigen,carbohydrate antigen 19-9,and squa-mous cell carcinoma antigen levels in esophageal cancer patients[J].World J Surg,2004,28(7):680-685.
8Mroczko B,Kozowski M,Groblewska M,et al.The diagnostic valueof the measurement of matrix metalloproteinase 9(MMP-9),squa-mous cell cancer antigen(SCC)and carcinoembryonic antigen(CEA)in the sera of esophageal cancer patients[J].Clin Chim Ac-ta,2008,389(1-2):61-66.
9Homma S,Harada M,Yano H,et al.Identification of squamouscell carcinoma antigen-derived peptides having the capacity of indu-cing cancer-reactive CTLs in HLA-A24+cancer patients[J].Int JOncol,2006,29(3):577-587.
10Gadducci A,Tana R,Fanucchi A,et al.Biochemical prognostic fac-tors and risk of relapses in patients with cervical cancer[J].GynecolOncol,2007,107(1 Suppl 1):23-26.
